NCT04615026已完成不适用
Prevalence of Thrombosis in COVID-Patients in Correlation to Humoral and Cellular Immunity
University Hospital Augsburg1 个研究点 分布在 1 个国家目标入组 525 人开始时间: 2020年11月4日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 525
- 试验地点
- 1
- 主要终点
- prevalence of thrombosis
研究概览
简要总结
Examination of the prevalence of thrombosis in COVID-patients, especially in an out-patient setting. Assessment by duplex sonography. If thrombosis is detected, we will correlate it with immunity status. Assessment of health issues and cognitive function as late complication after infection.
研究设计
- 研究类型
- Observational
- 观察模型
- Case Only
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •SARS CoV 2 positive swap, at least 4 weeks after infection
排除标准
- •under 18 years old no consent anemia
结局指标
主要结局
prevalence of thrombosis
时间窗: 20 minutes
次要结局
- Assessment of late complications(20 minutes)
- correlation to immunity(20 minutes)
研究者
Alexander Hyhlik-Dürr
Head of department
University Hospital Augsburg
研究点 (1)
Loading locations...
相似试验
已完成
不适用
Thromboembolic Complications in COVID-19 Patients in Intensive Care UnitCOVID-19-Associated ThromboembolismNCT06037707Ayse Zeynep Turan484
已完成
不适用
Study of COVID-19-related thromboembolism and chronic sequelae and prognosisCOVID-19JPRN-UMIN000047978ihon University Itabashi Hospital Department of Cardiology100
已完成
不适用
Practice Variation on Antithrombotics in COVID-19COVID-19 PneumoniaThrombosisCOVID-19 Acute Respiratory Distress SyndromeSevere Acute Respiratory Syndrome (SARS) PneumoniaNCT04998799NMC Specialty Hospital435
已完成
不适用
COVID-19 and Deep Venous ThrombosisCOVID-19Deep Vein Thrombosis (DVT)/ThrombophlebitisNCT04338932Jessa Hospital12
终止
3 期
Early Prophylactic Low-molecular-weight Heparin (LMWH) in Symptomatic COVID-19 Positive PatientsCOVID-19NCT04492254Thrombosis Research Institute219